López-Revilla R, Martínez H G, Santos-Díaz M S
Departamento de Biología Celular, Centro de Investigación y de Estudios Avanzados del IPN, México DF, Mexico.
Mol Gen Genet. 1988 Jul;213(1):105-11. doi: 10.1007/BF00333405.
To obtain animal cell lines carrying nonsense mutations and the corresponding suppressors, we used a "supersuppressor" selection strategy on the CHO cell line. The wild-type strain is resistant to the aminopterin present in HAT medium (i.e., it is HATr) because it contains the enzymes hypoxanthine-guanine phosphoribosyl transferase (HPRT) and thymidine kinase (TK), whereas both HPRT- mutants - selected by their resistance to 6-thioguanine (TGr) - and TK- mutants - selected by their resistance to 5-bromodeoxyuridine (BrdUrdr) - are HATs. Therefore, from HPRT- TK- double nonsense mutants, whose phenotype would be TGr BrdUrdr (HATs), simultaneous HPRT+ TK+ double phenotypic revertants could be obtained by selecting HATr (TGs BrdUrds) variants carrying the corresponding nonsense supersuppressors. Through ethylmethane sulfonate (EMS) mutagenesis of the CHO cell line we obtained 65 TGr variants, 53 of which were HATs and the rest HATr. Among 36 TGr (HATs) variants tested, 23 did not revert to HATr, 4 reverted spontaneously and with EMS, and 9 reverted only with EMS. Some of the latter were probably HPRT- nonsense mutants because they were very stringent (had less than 2% of wild-type [3H]hypoxanthine incorporation and HPRT enzyme activity), and did not complement genetically. The introduction of a second marker (BrdUrdr) in 7 of these strains allowed us to isolate 29 TGr BrdUrdr (HATs) double drug-resistant lines. Through one-step mutagenesis and selection in HAT medium, from two double resistant strains we could isolate HATr (TGs BrdUrds) wild-type phenotypic revertants, each of which probably carries suppressible HPRT and TK nonsense (or missense) alleles and the corresponding supersuppressor. Our strategy could now be extended to obtain variants carrying suppressors in other cell lines.
为了获得携带无义突变和相应抑制子的动物细胞系,我们在CHO细胞系上采用了“超级抑制子”选择策略。野生型菌株对HAT培养基中存在的氨基蝶呤具有抗性(即它是HATr),因为它含有次黄嘌呤 - 鸟嘌呤磷酸核糖基转移酶(HPRT)和胸苷激酶(TK),而通过对6 - 硫鸟嘌呤的抗性选择的HPRT-突变体(TGr)和通过对5 - 溴脱氧尿苷的抗性选择的TK-突变体(BrdUrdr)都是HATs。因此,从表型为TGr BrdUrdr(HATs)的HPRT- TK-双无义突变体中,通过选择携带相应无义超级抑制子的HATr(TGs BrdUrds)变体,可以获得同时具有HPRT+ TK+双表型回复体。通过对CHO细胞系进行甲基磺酸乙酯(EMS)诱变,我们获得了65个TGr变体,其中53个是HATs,其余是HATr。在测试的36个TGr(HATs)变体中,23个没有回复为HATr,4个自发回复且用EMS处理后回复,9个仅用EMS处理后回复。后者中的一些可能是HPRT-无义突变体,因为它们非常严格(野生型[3H]次黄嘌呤掺入和HPRT酶活性低于2%),并且在遗传上不互补。在其中7个菌株中引入第二个标记(BrdUrdr)使我们能够分离出29个TGr BrdUrdr(HATs)双耐药系。通过在HAT培养基中进行一步诱变和选择,从两个双耐药菌株中我们可以分离出HATr(TGs BrdUrds)野生型表型回复体,每个回复体可能携带可抑制的HPRT和TK无义(或错义)等位基因以及相应的超级抑制子。我们的策略现在可以扩展到在其他细胞系中获得携带抑制子的变体。